(QGEN) |
| 0 (0%) 04-14 16:59 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 51.03 |
| Resistance 1: | 43.69 |
| Pivot price: | 40.51 |
| Support 1: | 40.66 |
| Support 2: | 38.79 |
| 52w High: | |
| 52w Low: |
| EPS | 2.040 |
| Book Value | 18.330 |
| PEG Ratio | 0.00 |
| Gross Profit | 6.745 |
| Profit Margin (%) | 20.33 |
| Operating Margin (%) | 27.42 |
| Return on Assets (ttm) | 5.8 |
| Return on Equity (ttm) | 11.6 |
Tue, 14 Apr 2026
QIAGEN enters blood infection testing with a 1-hour lab panel - Stock Titan
Tue, 14 Apr 2026
QGEN Downgraded by Barclays -- Price Target Set at $44.00 - GuruFocus
Tue, 14 Apr 2026
Is Qiagen (QGEN) Offering Value After Mixed Share Price Performance? - simplywall.st
Tue, 14 Apr 2026
Barclays Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $44 - Moomoo
Tue, 14 Apr 2026
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio - MSN
Tue, 14 Apr 2026
Precision Trading with Qiagen N.v. (QGEN) Risk Zones - Stock Traders Daily
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |